LCMS-8050 Mass Spectrometer Increases Quality Analysis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

LCMS-8050 Mass Spectrometer Increases Quality Analysis


Pharmaceutical Technology
Volume 37, Issue 10, pp. 18
Untitled Document

The LCMS-8050 triple quadrupole mass spectrometer can perform both positive and negative ion analysis in a single run for faster throughput. The LCMS-8050 achieves high sensitivity through a patented ion optics system, a designed heated ESI probe, and UFsweeper III Collision Cell. The LCMS-8050 offers multiple reaction monitoring (MRM) speeds of 555 ch/sec and maintains spectrum quality, sensitivity, and accuracy at scan speeds up to 30,000 μ/sec. The Synchronized Survey Scan function allows users to obtain MRM data while simultaneously performing qualitative MS/MS scans. The LCMS-8050 provides 5-millisecond polarity switching and maintains ion intensity during polarity switching at high speeds. The ion source features a cable-free, tubeless housing when switching from ESI to APCI or dual-ionization mode.

Shimadzu Scientific Instruments

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
Source: Pharmaceutical Technology,
Click here